Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 3/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.37 |
| ▸ | MELK | Q14680 | 2/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4854062 | 1.00 | SYK (0.43) | SYKKDRCHRNA7MIFSLC6A9 | |
| SCHEMBL4853780 | 0.91 | SYK (0.43) | SYKSLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4854730 | 0.91 | SYK (0.43) | SYKSLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4854072 | 0.90 | KDR (0.41) | SYKKDRCHRNA7MELKCTSL | |
| SCHEMBL4852466 | 0.89 | MAPT (0.42) | SYKCHRNA7SLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4846630 | 0.89 | MAPT (0.42) | SYKCHRNA7SLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4849970 | 0.89 | SYK (0.44) | SYKKDRSLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4852900 | 0.89 | SYK (0.44) | SYKKDRSLC6A9TNFRSF1AKDM4E | |
| SCHEMBL4852212 | 0.85 | BCHE (0.44) | SYK | |
| SCHEMBL4853723 | 0.85 | BCHE (0.44) | SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | disclosed |